July 9, 2020 / 4:17 PM / a month ago

BRIEF-Qiagen Q2 Net Sales Rose About 18-19% Compared To Year Ago

July 9 (Reuters) - QIAGEN NV:

* Q2 NET SALES ROSE APPROXIMATELY 18-19% AT CONSTANT EXCHANGE RATES (CER) FROM $381.6 MILLION IN SAME PERIOD OF 2019

* BETTER-THAN-EXPECTED NET SALES GROWTH REFLECTS VERY SIGNIFICANT DEMAND FOR SOLUTIONS USED IN COVID-19 PANDEMIC TESTING AGAINST WEAKER CUSTOMER DEMAND TRENDS IN OTHER PRODUCT AREAS

* CONTINUES TO EXPERIENCE UNPRECEDENTED DEMAND FOR PRODUCTS USED IN CORONAVIRUS TESTING

* EXPECTS CURRENCY MOVEMENTS AGAINST U.S. DOLLAR (REPORTING CURRENCY) TO HAVE AN ADVERSE IMPACT ON RESULTS FOR Q2 OF 2020 OF ABOUT 2-3 PERCENTAGE POINTS ON NET SALES AT ACTUAL RATES Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below